Finally, additional studies employing in vitro and in vivo DKD models, combined with Western blotting, immunostaining, and functional inhibition assays targeting ITGB6 and LTBP1, are necessary to elucidate their roles in cuproptosis and inflammatory signaling under hyperglycemic conditions. Here, LTBP1 is linked to diabetic kidney disease.